Daulet Berikbol | Oncology | Scientific Advancement Achievement Award

Published on by Global Scholar Awards

Dr. Daulet Berikbol | Oncology | Scientific Advancement Achievement Award

UMIT International Oncology Center for Tomotherapy, LLP | Kazakhstan

Dr. Berikbol Daulet is a medical researcher at the UMIT International Oncological Center of Tomotherapy, Astana, Kazakhstan, with expertise in radiation oncology, tomotherapy, and advanced cancer treatment strategies. His research focuses on integrating precision radiotherapy with immunological and cellular therapies to improve outcomes in complex and advanced-stage cancers. He has authored 4 peer-reviewed publications, received 2 citations, and holds an h-index of 1, reflecting focused and emerging contributions to clinical oncology. Dr. Daulet actively engages in multidisciplinary clinical and translational research, contributing to collaborative studies that bridge radiotherapy and immunotherapy. His recent open-access case report on combined tomotherapy and autologous peripheral-blood–derived lymphocyte infusion for stage IIIa lung cancer highlights innovative, patient-centered treatment approaches, particularly for elderly patients. Through applied clinical research, he supports evidence-based oncology practice, advances modern cancer treatment technologies, and contributes to improved patient outcomes and broader societal benefit in healthcare.

Citation Metrics (Scopus)

4
3
2
1
0

Citations

2

Documents

4

h-index

1

Citations

Documents

h-index

View Scopus Profile View ORCID Profile

Featured Publications

Mahmoud Mansour | Pharmacology | Best Researcher Award

Published on by Global Scholar Awards

Prof. Mahmoud Mansour | Pharmacology | Best Researcher Award

Professor | King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Dr. Mahmoud Ahmed Mansour is a biomedical researcher affiliated with King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, with recognized expertise in biochemical toxicology, oxidative stress, pharmacology, and cancer biology. His research primarily focuses on the molecular mechanisms of hepatocarcinogenesis, proteasome inhibition, antioxidant defense systems, and cardiometabolic complications. Dr. Mansour has authored 40 peer-reviewed publications, accumulating over 1,879 citations, with an h-index of 18, reflecting sustained scientific impact and scholarly influence. His highly cited works explore the antineoplastic potential of proteasome inhibitors such as carfilzomib, as well as oxidative stress in metabolic and reproductive health conditions. He has collaborated with more than 50 international co-authors, demonstrating strong interdisciplinary and cross-institutional engagement. The societal relevance of his research lies in advancing therapeutic strategies for cancer prevention, metabolic disorders, and drug-induced toxicity, contributing to improved clinical understanding and translational biomedical outcomes at a global level.

Citation Metrics (Scopus)

1879
1400
900
400
0

Citations

1,879

Documents

40

h-index

18

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Marla Shapiro C.M. | Medicine and Dentistry | Research Excellence Award

Published on by Global Scholar Awards

Dr. Marla Shapiro C.M. | Medicine and Dentistry | Research Excellence Award

Professor | University of Toronto | Canada

Dr. Marla Shapiro is an Associate Professor at the University of Toronto, Canada, specializing in menopause research, vasomotor symptoms, and women’s midlife health. Her scholarship focuses on advancing evidence-based, non-hormonal and hormonal therapeutic strategies for managing moderate to severe menopausal symptoms. She has published 34 peer-reviewed articles, receiving 1,713 citations, with an h-index of 14, demonstrating consistent academic influence. Dr. Shapiro has played a key role in international phase 3 and 3b clinical trials, including responder and pooled analyses of fezolinetant, published in leading journals such as Maturitas and Menopause. Through collaborations with more than 180 international co-authors, her work has informed clinical decision-making, supported guideline development, and contributed meaningfully to improving quality of life and healthcare outcomes for menopausal women worldwide.

Citation Metrics (Scopus)

1713
1200
800
400
0

Citations

1,713

Documents

34

h-index

14

Citations

Documents

h-index

View Scopus Profile
 View ResearchGate Profile

Featured Publications

Sibel Mataraci Karakas | Medical Biochemistry | Excellence in Research Award

Published on by Global Scholar Awards

Dr. Sibel Mataraci Karakas | Medical Biochemistry | Excellence in Research Award

Recep Tayyip Erdogan University | Turkey

Dr. Sibel Mataracı Karakaş is a researcher at Recep Tayyip Erdoğan University, Rize, Turkey, specializing in oral health sciences and periodontology. Her research centers on oxidative stress, alveolar bone loss, and inflammatory mechanisms, with strong emphasis on experimental and translational models relevant to dental diseases. She has authored multiple peer-reviewed publications that have received steady academic recognition, reflecting the quality and relevance of her work. Dr. Karakaş maintains active collaboration with national and international researchers, supporting interdisciplinary knowledge exchange. Her recent open-access research highlights the preventive role of bioactive compounds in periodontal conditions, contributing valuable insights for therapeutic development. Through evidence-based research, she supports improved preventive strategies, advances clinical understanding of periodontal disease, and contributes to the promotion of oral health and societal well-being at a broader level.

Citation Metrics (Scopus)

63
45
30
15
0

Citations

63

Documents

17

h-index

5

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications

Cornelia Amalinei | Pathology | Research Excellence Award

Published on by Global Scholar Awards

Prof. Dr. Cornelia Amalinei | Pathology | Research Excellence Award

University of Medicine and Pharmacy “Grigore T. Popa” | Romania

Dr. Cornelia Amălinei is a distinguished researcher at Universitatea de Medicină și Farmacie “Grigore T. Popa” Iași, specializing in oncology, molecular biology, metabolic disorders, and translational medicine. Her research focuses on colorectal cancer, adipose tissue–neural crosstalk, and the role of adipose tissue in carcinogenesis, alongside exploring novel therapeutic strategies for metabolic and neoplastic diseases. Dr. Amălinei has authored 100 publications, cited over 952 times, with an h-index of 14, reflecting the impact of her work. She collaborates with more than 130 international co-authors, contributing to cross-disciplinary studies in molecular oncology, stem cell biology, and pharmacological interventions. Her work advances the understanding of disease mechanisms, informing predictive, diagnostic, and therapeutic approaches, thereby enhancing clinical translation and societal health outcomes.

Citation Metrics (Scopus)

952
700
500
250
0

Citations

952

Documents

100

h-index

14

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile View ORCID Profile

Featured Publications


Matrix metalloproteinases involvement in pathologic conditions

– Romanian Journal of Morphology and Embryology, 2010 · Cited by 406 


Biology of metalloproteinases

– Romanian Journal of Morphology and Embryology, 2007 · Cited by 273 


Perirenal adipose tissue—current knowledge and future opportunities

– Journal of Clinical Medicine, 2021 · Cited by 77 


The value of PAX8 and WT1 molecules in ovarian cancer diagnosis

– Romanian Journal of Morphology and Embryology, 2013 · Cited by 66 

Giuseppina Peluso | Medicine and Dentistry | Excellence in Research Award

Published on by Global Scholar Awards

Dr. Giuseppina Peluso | Medicine and Dentistry | Excellence in Research Award

Dirigente Responsabile | Azienda Ospedaliera | Italy

Dr. Giuseppina Peluso is a researcher at the AO of Cosenza in Italy, specializing in reproductive biology with an emphasis on the molecular and cellular mechanisms governing human sperm function. Her work explores the balance between pro-survival and pro-apoptotic pathways, offering deeper insight into the biological foundations of male infertility. Through sustained scientific contributions and broad interdisciplinary collaborations, she advances understanding of how molecular signaling influences sperm quality and reproductive potential. Her research supports the development of innovative therapeutic approaches and contributes to improving clinical strategies in andrology and reproductive health. Peluso’s commitment to evidence-based investigation continues to generate meaningful impact within both scientific and healthcare communities.

Citation Metrics (Scopus)

103
75
50
25
0

Citations

103

Documents

12

h-index

6

Citations

Documents

h-index

View Scopus Profile View ORCID Profile

Featured Publications

Patrice X. Petit | Signal Transduction | Best Researcher Award

Published on by Global Scholar Awards

Dr. Patrice X. Petit | signal transduction | Best Researcher Award

 Research director | Centre National de la Recherche Scientifique | France

Dr. Patrice X. Petit, Doctor ès Sciences and PhD in Biology, is a Research Director at the French National Centre for Scientific Research (CNRS), where he has served since 1979 and established an internationally recognized career in cell biology. Trained at the Université Pierre et Marie Curie and the Université Denis Diderot (Paris), his work has focused on the molecular mechanisms governing cell death, mitochondrial dynamics, oxidative stress, and their implications in cancer biology, immunology, and toxicology. Over more than four decades, he has developed a broad international scientific presence through extensive teaching and research collaborations across Europe, North America, and Asia, including academic engagements with institutions such as the Chinese Academy of Sciences, Caltech, UT Southwestern, the Beatson Cancer Research Center in Glasgow, the University of Madrid, and multiple leading universities throughout Scandinavia, Germany, and France. His scientific leadership is further reflected in his service as an elected member (2016–2020) of the Scientific Council of the CNRS Institute of Biological Sciences (INSB). Dr. Petit has authored 134 scientific publications, accumulating approximately 12,500 citations and an h-index of 44, demonstrating sustained research influence across several biomedical domains, including contributions to plant biology. He is an active peer reviewer for major journals such as Cancer Research, Journal of Cell Biology, PNAS, Oncogene, and Cell Death and Differentiation, and he has served as a grant reviewer for major funding bodies, including the Austrian Academy of Sciences, the French National Research Agency (ANR), EMBO, the Swiss National Science Foundation, and the Fondation pour la Recherche Médicale. His interdisciplinary background—ranging from a formal qualification in history (Université Paris Diderot, 1979) to a DIU in rare diseases (Université de Strasbourg, 2017)—underscores both scientific depth and broader intellectual engagement. Through his sustained research output, international collaborations, and service to the scientific community, Patrice X. Petit has contributed significantly to advancing fundamental and translational knowledge in cell biology, with measurable societal impact across biomedical research and education.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., … Petit, P. X. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. The Journal of Experimental Medicine, 182(2), 367–377.

Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., … Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. The Journal of Experimental Medicine, 181(5), 1661–1672.

Kroemer, G., Petit, P., Zamzami, N., Vayssière, J. L., & Mignotte, B. (1995). The biochemistry of programmed cell death. The FASEB Journal, 9(13), 1277–1287.

Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. The Journal of Cell Biology, 130(1), 157–167.

Petit, P. X., Susin, S. A., Zamzami, N., Mignotte, B., & Kroemer, G. (1996). Mitochondria and programmed cell death: Back to the future. FEBS Letters, 396(1), 7–13.

Dr. Petit’s work has fundamentally advanced our understanding of mitochondrial biology and programmed cell death, shaping modern concepts of apoptosis, autophagy, and cellular stress responses. His discoveries enabled new biomedical approaches to cancer, immunology, and rare diseases

Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Published on by Global Scholar Awards

Prof. Dr. Shaoqing Yu | Medicine and Dentistry | Best Researcher Award

Directors of Department in Hospital| Tongji University | China

Dr. Shaoqing Yu, PhD, is the Director of the Departments of Otorhinolaryngology–Head and Neck Surgery and Allergy at Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. An accomplished clinician-scientist, Dr. Yu specializes in allergy, immunology, and otorhinolaryngology, with a research focus on the mechanisms and clinical management of allergic rhinitis and upper airway inflammation. He has led or participated in more than 20 major research projects, including those funded by the National Natural Science Foundation of China, and has published over 70 peer-reviewed papers in high-impact international journals such as JAMA, Allergy, Clinical and Experimental Allergy, and Clinical Reviews in Allergy & Immunology. His work has substantially advanced understanding of immune regulation and translational therapies in allergic diseases. Dr. Yu is an active member of the European Academy of Allergy and Clinical Immunology (EAACI) and the Chinese Society of Otolaryngology in Traditional Chinese and Western Medicine, fostering global and interdisciplinary collaborations. His achievements have been recognized through numerous awards, including the Third Prize of the Shanghai Medical Technology Award, the Third Prize of the Military Medical Achievement Award, and the Tongji University Taihe Medical Education Award. With over 20 patents to his name and selection for the prestigious Shanghai Oriental Talent Plan, Dr. Yu continues to contribute significantly to medical innovation, education, and the improvement of public health outcomes in China and internationally.

Profiles: Scopus | ORCID 

Featured Publications

Yu, S., et al. (2025). An anti-TSLP monoclonal antibody for uncontrolled CRSwNP: The DUBHE randomized clinical trial. Nature Communications.

Yu, S., et al. (2025). Efficacy and safety of intranasal corticosteroids combined with mucoactive drugs for chronic rhinosinusitis. International Immunopharmacology.

Yu, S., et al. (2025). Xylulose 5-phosphate fosters sustained antitumor activity of progenitor-like exhausted SLC35E2⁺ CD8⁺ T effector cells. Cell Metabolism.

Yu, S., et al. (2025). Automatic segmentation of clear cell renal cell carcinoma based on deep learning and a preliminary exploration of the tumor microenvironment. Translational Andrology and Urology.

Yu, S., et al. (2025). Long-term administration of hydrogen-rich water enhances quality of life in diabetic rats and reduces renal neoplasm incidence through modulation of inflammatory and metabolic pathways. Translational Andrology and Urology.

Dr. Shaoqing Yu’s pioneering research in allergy and immunology has advanced understanding of airway inflammatory diseases and driven the development of innovative diagnostic and therapeutic strategies. His work bridges basic science and clinical application, improving patient outcomes and shaping global standards in allergic disease management.

Ragunath Cholaraj | Biological Sciences | Best Researcher Award

Published on by Global Scholar Awards

Dr. Ragunath Cholaraj | Biological Sciences | Best Researcher Award

Guest Faculty | Periyar University | India

Dr. Ragunath Cholaraj is a distinguished researcher and academician with extensive expertise in Zoology and Biotechnology, particularly in the field of Aquatic Biotechnology. He holds advanced degrees including dual Master of Science qualifications in Zoology and Biotechnology, an M.Phil., and a Ph.D. from Bharathiar University, where his doctoral research focused on the immunomodulatory effects of fucoidan derived from marine seaweeds on fish immune systems. Professionally, he serves as a Guest Faculty at Periyar University, Salem, and has previously worked as a Research Fellow under the Rashtriya Uchchatar Shiksha Abhiyan (RUSA 2.0) and as a Quality Control Executive at AMEYA Foods (Marico Pvt. Ltd.). His research interests encompass biotechnology, aquaculture, immunology, molecular biology, phytomedicine, cancer biology, nanotechnology, and microbiology. He is proficient in advanced laboratory techniques including molecular diagnostics, nucleic acid analysis, gene expression studies, nanoparticle synthesis, and biochemical assays such as ELISA and Western blotting. As an active journal reviewer for several international journals, he contributes significantly to scholarly peer review. His research accomplishments are reflected in numerous publications in reputed Scopus and SCI-indexed journals, with impactful work on marine bioactive compounds, nanotechnology applications, and immunological studies in aquaculture species. Dr. Ragunath has received several accolades, including the “Young Researcher Award” from the Institute of Scholars and multiple prizes for poster presentations at national and international conferences. His participation in various workshops and faculty development programs highlights his commitment to continuous learning and scientific advancement. Overall, Dr. Ragunath Cholaraj exemplifies a dedicated researcher whose contributions to aquatic biotechnology and interdisciplinary life sciences continue to promote innovation, sustainability, and academic excellence in biological research.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Karthik, M., Ragunath, C., Krishnasamy, P., Paulraj, D. Q., & Ramasubramanian, V. (2023). Green synthesis of zinc oxide nanoparticles using Annona muricata leaf extract and its antioxidant and antibacterial activity. Inorganic Chemistry Communications, 157, 111422. Cited by: 27.

  2. Ragunath, C., Kumar, Y. A. S., Kanivalan, I., & Radhakrishnan, S. (2020). Phytochemical screening and GC-MS analysis of bioactive constituents in the methanolic extract of Caulerpa racemosa (Forssk.) J. Agardh and Padina boergesenii Allender & Kraft. Current Applied Science and Technology, 380–393. Cited by: 26.

  3. Cholaraj, R., & Venkatachalam, R. (2024). Investigation of antioxidant and anticancer potential of fucoidan (in-vitro & in-silico) from brown seaweed Padina boergesenii. Algal Research, 79, 103442. Cited by: 18.

  4. Ragunath, C., & Ramasubramanian, V. (2022). Dietary effect of Padina boergesenii on growth, immune response, and disease resistance against Pseudomonas aeruginosa in Cirrhinus mrigala. Applied Biochemistry and Biotechnology, 1(1), 1–12. Cited by: 13.

  5. Ragunath, C., Kousalya, L., Venkatachalam, R., & Anitha, S. (2022). Green synthesis of hydroxyapatite nanoparticles from Wrightia tinctoria and its antibacterial activity. BioNanoScience, 12(3), 723–730. Cited by: 12.

 

Imran Shair Mohammad | Drug Delivery | Best Researcher Award

Published on by Global Scholar Awards

Dr. Imran Shair Mohammad | Drug Delivery | Best Researcher Award

Postdoctoral Fellow | City of Hope National Medical Center | United States

Dr. Imran Shair Mohammad is a distinguished pharmaceutical scientist whose research focuses on developing next-generation minimally invasive cancer immunotherapies through the design of innovative drug delivery systems and biomaterials. His work lies at the intersection of drug discovery, mRNA and peptide engineering, and biomaterial science, with an emphasis on creating nano/microparticle and hydrogel-based systems for targeted delivery of exosomes, RNA, peptides, and small molecules to improve therapeutic outcomes in cancer, inflammation, and infectious diseases. He earned his Ph.D. in Pharmaceutics from China Pharmaceutical University, Nanjing, following an M.Phil and Pharm.D. from The Islamia University of Bahawalpur, Pakistan. Professionally, Dr. Mohammad has held several postdoctoral research positions across leading international institutions, including the University of North Carolina at Chapel Hill, Erciyes University in Turkey, Sun Yat-sen University in China, and currently serves at the City of Hope National Medical Center, USA. His expertise spans drug and gene delivery, mRNA and peptide synthesis, protein engineering, and immunomodulatory biomaterials, with hands-on proficiency in nanoparticle development, polymer chemistry, and advanced analytical techniques such as HPLC, TEM, and LC-MS. His research interests encompass cancer immunotherapy, drug resistance, cellular engineering, and microbiome-based therapeutics. Dr. Mohammad has published over 40 peer-reviewed articles, received multiple international research grants from the USA, Turkey, and China, and serves on the editorial boards of Cancer Immunology Connect and Current Drug Delivery. Recognized with prestigious honors such as the High-Level Foreign Talents Award from Guangdong Province and the Chinese Government Ph.D. Scholarship, he continues to contribute to advancing translational nanomedicine and targeted immunotherapeutic strategies. His career exemplifies a commitment to scientific innovation, interdisciplinary collaboration, and impactful research that bridges laboratory discoveries with clinical applications for global health advancement.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

1. Mohammad, I. S., He, W., & Yin, L. (2018). Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR. Biomedicine & Pharmacotherapy, 100, 335–348. https://doi.org/10.1016/j.biopha.2018.02.028 Cited by: 226

2. Mohammad, I. S., Hu, H., Yin, L., & He, W. (2019). Drug nanocrystals: Fabrication methods and promising therapeutic applications. International Journal of Pharmaceutics, 562, 187–202. https://doi.org/10.1016/j.ijpharm.2019.03.055 Cited by: 163

3. Ishaq, H. M., Mohammad, I. S., Guo, H., Shahzad, M., Hou, Y. J., Ma, C., Naseem, Z., … (2017). Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients. Biomedicine & Pharmacotherapy, 95, 865–874. https://doi.org/10.1016/j.biopha.2017.08.097 Cited by: 134

4. Wang, X., Mohammad, I. S., Fan, L., Zhao, Z., Nurunnabi, M., Sallam, M. A., Wu, J., … (2021). Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharmaceutica Sinica B, 11(8), 2585–2604. https://doi.org/10.1016/j.apsb.2021.03.013 Cited by: 130

5. Gu, Y., Mohammad, I. S., & Liu, Z. (2020). Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors. Oncology Letters, 19(4), 2585–2594. https://doi.org/10.3892/ol.2020.11309 Cited by: 120